Oncozine.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
80% 
Page quality
64% 
Page structure
58% 
Link structure
0% 
Server
86% 
External factors
100% 
SEO Score
Response time
1.01 s
File size
221.30 kB
Words
1884
Media files
8
Number of links
283 internal / 75 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Home - Onco'Zine - A part of the Oncology and Hematology News Network
The page title should be shorter than 580 pixels. It is 670 pixels long. Optimize title
There are no duplicate words in the title
Meta description
(Critically important)
Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer
The length of the meta description is perfect. (887 pixels out of 1000 max pixel length)
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.oncozine.com/
There is a valid canonical link specified.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en-us
Server location: United States of America
The following language is defined by HTML: en-us
Alternate/Hreflang Links
(Somewhat important)
There are no alternate links specified on this page.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
viewportwidth=device-width, initial-scale=1.0
robotsindex, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1
descriptionOnco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer
msvalidate.01325DBF0B4415B7D5F77949B32086EEB2
google-site-verificationDvS50_-wX_jjHKRtegP7b3R6lPTOcwGV7N7mm1J2oAk
generatorWordPress 6.5.5
msapplication-TileImagehttps://www.oncozine.com/wp-content/uploads/2018/09/cropped-circle-270x270.png
article:publisherhttps://www.facebook.com/oncozine.journal
article:modified_time2023-11-14T01:28:40+00:00
langen-us
twitter:cardsummary_large_image
twitter:site@OncoZine
fb:pageshttps://www.facebook.com/OncoZine/
og:localeen_US
og:typewebsite
og:titleHome - Onco'Zine - A part of the Oncology and Hematology News Network
og:descriptionOnco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer
og:urlhttps://www.oncozine.com/
og:site_nameOnco'Zine
charsetUTF-8

Test up to 1.000 webpages of oncozine.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Some words from the page title are not used within the pages content
Only 1 paragraph/s was/were found on this page.
These Typos were found:
  • advertisment => advertisement
This page contains 1884 words. That's ok.
24.3% of the text are stop words.
Words from the H1 heading are used in the page content.
The page contains a listing, which indicates a good text layout.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 21 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
A viewport "width=device-width, initial-scale=1.0" is provided.
At least one Apple touch icon is specified.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 38 tags for this page.
Image SEO
(Somewhat important)
1 images have no alt attribute. The content of alt attributes is used by search engines.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
...tent/uploads/2019/06/oncozine_270x90.pngOncoZine, The International Oncology NetworkOncoZine, The International Oncology Network
.../uploads/2019/06/oncozine-140x48_wht.pngOncoZine, The International Oncology NetworkOncoZine, The International Oncology Network
...tent/uploads/2019/06/oncozine_270x90.pngOncoZine, The International Oncology NetworkOncoZine, The International Oncology Network
...ads/2020/02/oncozine_brief-300x250-1.pngspot_img
...F4D-4F06-AB10-E80D755FFC56_4_5005_c.jpegspot_img
...ers-of-the-Cancer-Universe-300x250-1.jpgspot_img
.../uploads/2019/06/oncozine_270x90_wht.pngOnco\'Zine, The International Oncology NetworkOnco\'Zine, The International Oncology Network
...nt/uploads/2021/05/subcription-popup.pngNo alt attribute provided

Page structure

H1 heading
(Critically important)
Onco'Zine OncoZine, The International Oncology Network
The H1 heading is perfect.
Headings
(Important)
Some headings occur twice on the page.
The structure of headings is missing one or more levels. Do not skip heading levels.
There are 61 headings on the page. The amount of headings should be in a more proper relation to the amount of text.

Heading structure

Heading levelContent
H1 Onco'Zine OncoZine, The International Oncology Network
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
H3 Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
H3 The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
H3 ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Duplicate text
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Duplicate text
H3 The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Duplicate text
H3 The Transformative Potential of Exosome Research in Cancer Detection and Beyond
H3 A Global View of Oncology Informatics
H3 Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
H3 Experts Forecast: Achieving Cancer Health Equity
H3 The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Duplicate text
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Duplicate text
H3 Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Duplicate text
H3 The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Duplicate text
H3 ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Duplicate text
H3 ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
H3 ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
H3 ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic...
H3 ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
H3 ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
H3 ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its...
H3 Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab
H3 ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Duplicate text
H3 ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC Duplicate text
H3 ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma Duplicate text
H3 ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... Duplicate text
H3 ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n Duplicate text
H3 ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer Duplicate text
H3 ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... Duplicate text
H3 ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies
H3 Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer
H3 Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy
H3 Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
H3 Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer
H3 A Global View of Oncology Informatics Duplicate text
H3 Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System Duplicate text
H3 Experts Forecast: Achieving Cancer Health Equity Duplicate text
H3 The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation Duplicate text
H3 Forecast 2024: Broadening the Reach of Cancer Vaccines
H3 The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care
H3 Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
H3 Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
H3 Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources
H3 SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer
H3 Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Duplicate text
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Duplicate text
H3 Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Duplicate text
H3 Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics
H3 How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?
H3 Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...
H4 FEATURED
H4 NEWS
H4 CONFERENCE COVERAGE
H4 EDITORIAL
H4 ERIC ROSENTHAL REPORTS
H4 EXPERT INTERVIEWS
Some anchor texts are used more than once.
The number of internal links is ok.
None of the anchor texts is too long.
All internal links are not using dynamic parameters.
There are too many external links (75) on this page.

Found links on this page

LinkAttributesAnchor text
https://www.facebook.com/oncoz...New window External Subdomain A-TITLE Facebook
https://www.linkedin.com/showc...New window External Subdomain A-TITLE Linkedin
https://soundcloud.com/hofreyNew window External A-TITLE Soundcloud
https://twitter.com/OncoZineNew window External A-TITLE Twitter
https://vimeo.com/channels/877242New window External A-TITLE Vimeo
https://www.youtube.com/channe...New window External Subdomain A-TITLE Youtube
https://www.xing.com/communiti...New window External Subdomain A-TITLE Xing
https://www.oncozine.com/Subdomain Home
/advertisement-sponsorship-opt...Subdomain Advertisement & Sponsorship Options
https://lp.constantcontactpage...External Subdomain Download Our Media Kit
/continued-medical-education-cme/Subdomain Changing Physician Behavior
/cancer-information-by-disease/Subdomain Cancer A – Z
http://www.oncozine.com/Subdomain Drug Developmemt Technologies
/a-novel-technology-based-on-s...Subdomain A Novel Technology based on Somatic Hypermutation (SHM)
/about-oncozine/advisory-board-3/Subdomain Editorial Advisory Board
/join-our-editorial-advisory-b...Subdomain Join Our Editorial Advisory Board
/contact-us/Subdomain Contact Us
/terms-and-conditions/Subdomain Terms and Conditions
/sabcs-and-ash-2023/Subdomain SABCS and ASH 2023
http://www.adcreview.com/External Subdomain ADC Review | J. Antibody-drug Conjugates
https://www.adcreview.com/reso...External Subdomain Resources for For Clinicians
https://www.adcreview.com/adc-...External Subdomain Drug Map (ADC)
https://www.adcreview.com/cate...External Subdomain Peer Review Articles
https://www.adcreview.com/the-...External Subdomain The Review
/changing-strategies-in-the-wa...Subdomain Changing Strategies in the War on Cancer
/changing-strategies-in-the-wa...Subdomain Changing Strategies in the War on Cancer – Episode 1
/changing-strategies-in-the-wa...Subdomain Changing Strategies in the War on Cancer – Episode 2
/changing-strategies-in-the-wa...Subdomain Changing Strategies in the War on Cancer – Episode 3
/centers-of-the-cancer-univers...Subdomain Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
http://cartcelljournal.com/External Journal of CAR T-Cell Therapy
http://cartcelljournal.com/about/External About CAR T-cells
http://cartcelljournal.com/faq/External Frequently Asked Questions
http://cartcelljournal.com/art...External Types of Articles
http://cartcelljournal.com/for...External Submit a Manuscript
/the_oncozine_brief_episodes/Subdomain The Onco’Zine Brief
/the_oncozine_brief_episodes/Subdomain The Network
/the-oncozine-brief-episodes/Subdomain The Episodes
https://www.patreon.com/theonc...New window External Subdomain How to Support The Onco’Zine Brief
/underwriting/Subdomain Corporate Underwriting and Sponsorship
/the-oncozine-dossier/Subdomain The Onco’Zine Dossier
/thalidomide-a-history/Subdomain Thalidomide: A History
/thalidomide-in-the-shadow-of-...Subdomain Thalidomide: In the Shadow of Death
/controversy-the-involvement-o...Subdomain Controversy: The involvement of Ciba AG in the development of Thalidomide
/thalidomides-secret-past-the-...Subdomain Thalidomide’s Secret Past: The Link with Nazi Germany
/reversal-of-fortune-how-a-vil...Subdomain Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/oncozine-dossier-50-years-aft...Subdomain Smoking and Health
/new-surgeon-generals-report-p...Subdomain New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
/smoking-and-the-lost-legacy-o...Subdomain Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
/tobacco-control-in-the-united...Subdomain Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
http://.com/tobacco-companies-...External Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
/the-harmful-effects-of-smokin...Subdomain The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
/oncozine.com/oncology-hematol...Subdomain Drug Approvals 2017 – 2020
/oncology-hematology-drug-appr...Subdomain Oncology & Hematology – FDA Drug Approvals 2018
/oncology-hematology-fda-drug-...Subdomain Oncology & Hematology – FDA Drug Approvals 2019
/oncology-hematology-fda-drug-...Subdomain Oncology & Hematology – FDA Drug Approvals 2020
/category/articles/Subdomain Articles
/category/latest-articles/Subdomain Latest Articles
/category/expert-interviews/Subdomain Expert Interviews
/category/editorial-and-commen...Subdomain Editorials and Commentaries
/category/eric-rosenthal-reports/Subdomain Eric Rosenthal Reports
/category/publications-peer-re...Subdomain Publications
/category/news/Subdomain News
/category/business-economics/Subdomain Business & Economics
/category/clinical-development/Subdomain Clinical Development
/category/conference-coverage/Subdomain Conference Coverage
/the_oncozine_brief_episodes/Subdomain Text duplicate The Onco’Zine Brief
/the-oncozine-brief-episodes/Subdomain Text duplicate The Episodes
/the-oncozine-brief-national-a...Subdomain National Advertising
http://www.oncozine.com/New window Subdomain Resources
https://www.oncologydirectory....New window External Subdomain Membership
https://www.oncologydirectory....External Subdomain Agenda
https://www.oncologydirectory....New window External Subdomain Join Today
https://www.oncologydirectory....New window External Subdomain Video
/job-openings/Subdomain Careers
/about-oncozine/about-oncozine-2/Subdomain About
/about-oncozine/advertise-with...Subdomain Advertise
/about-oncozine/advisory-board...Subdomain Advisory Board
/contact-us/Subdomain Text duplicate Contact Us
https://www.facebook.com/oncoz...New window External Subdomain Text duplicate A-TITLE Facebook
https://www.linkedin.com/showc...New window External Subdomain Text duplicate A-TITLE Linkedin
https://soundcloud.com/hofreyNew window External Text duplicate A-TITLE Soundcloud
https://twitter.com/OncoZineNew window External Text duplicate A-TITLE Twitter
https://vimeo.com/channels/877242New window External Text duplicate A-TITLE Vimeo
https://www.youtube.com/channe...New window External Subdomain Text duplicate A-TITLE Youtube
https://www.xing.com/communiti...New window External Subdomain Text duplicate A-TITLE Xing
https://www.oncozine.com/Subdomain Onco'Zine
IMG-ALT OncoZine, The International Oncology Network
https://www.oncozine.com/Subdomain IMG-ALT OncoZine, The International Oncology Network
https://www.oncozine.com/Subdomain Text duplicate IMG-ALT OncoZine, The International Oncology Network
https://www.oncozine.com/Subdomain Text duplicate Home
/advertisement-sponsorship-opt...Subdomain Text duplicate Advertisement & Sponsorship Options
https://lp.constantcontactpage...External Subdomain Text duplicate Download Our Media Kit
/continued-medical-education-cme/Subdomain Text duplicate Changing Physician Behavior
/cancer-information-by-disease/Subdomain Text duplicate Cancer A – Z
http://www.oncozine.com/Subdomain Text duplicate Drug Developmemt Technologies
/a-novel-technology-based-on-s...Subdomain Text duplicate A Novel Technology based on Somatic Hypermutation (SHM)
/about-oncozine/advisory-board-3/Subdomain Text duplicate Editorial Advisory Board
/join-our-editorial-advisory-b...Subdomain Text duplicate Join Our Editorial Advisory Board
/contact-us/Subdomain Text duplicate Contact Us
/terms-and-conditions/Subdomain Text duplicate Terms and Conditions
/sabcs-and-ash-2023/Subdomain Text duplicate SABCS and ASH 2023
http://www.adcreview.com/External Subdomain Text duplicate ADC Review | J. Antibody-drug Conjugates
https://www.adcreview.com/reso...External Subdomain Text duplicate Resources for For Clinicians
https://www.adcreview.com/adc-...External Subdomain Text duplicate Drug Map (ADC)
https://www.adcreview.com/cate...External Subdomain Text duplicate Peer Review Articles
https://www.adcreview.com/the-...External Subdomain Text duplicate The Review
/changing-strategies-in-the-wa...Subdomain Text duplicate Changing Strategies in the War on Cancer
/changing-strategies-in-the-wa...Subdomain Text duplicate Changing Strategies in the War on Cancer – Episode 1
/changing-strategies-in-the-wa...Subdomain Text duplicate Changing Strategies in the War on Cancer – Episode 2
/changing-strategies-in-the-wa...Subdomain Text duplicate Changing Strategies in the War on Cancer – Episode 3
/centers-of-the-cancer-univers...Subdomain Text duplicate Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
http://cartcelljournal.com/External Text duplicate Journal of CAR T-Cell Therapy
http://cartcelljournal.com/about/External Text duplicate About CAR T-cells
http://cartcelljournal.com/faq/External Text duplicate Frequently Asked Questions
http://cartcelljournal.com/art...External Text duplicate Types of Articles
http://cartcelljournal.com/for...External Text duplicate Submit a Manuscript
/the_oncozine_brief_episodes/Subdomain Text duplicate The Onco’Zine Brief
/the_oncozine_brief_episodes/Subdomain Text duplicate The Network
/the-oncozine-brief-episodes/Subdomain Text duplicate The Episodes
https://www.patreon.com/theonc...New window External Subdomain Text duplicate How to Support The Onco’Zine Brief
/underwriting/Subdomain Text duplicate Corporate Underwriting and Sponsorship
/the-oncozine-dossier/Subdomain Text duplicate The Onco’Zine Dossier
/thalidomide-a-history/Subdomain Text duplicate Thalidomide: A History
/thalidomide-in-the-shadow-of-...Subdomain Text duplicate Thalidomide: In the Shadow of Death
/controversy-the-involvement-o...Subdomain Text duplicate Controversy: The involvement of Ciba AG in the development of Thalidomide
/thalidomides-secret-past-the-...Subdomain Text duplicate Thalidomide’s Secret Past: The Link with Nazi Germany
/reversal-of-fortune-how-a-vil...Subdomain Text duplicate Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/oncozine-dossier-50-years-aft...Subdomain Text duplicate Smoking and Health
/new-surgeon-generals-report-p...Subdomain Text duplicate New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
/smoking-and-the-lost-legacy-o...Subdomain Text duplicate Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
/tobacco-control-in-the-united...Subdomain Text duplicate Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
http://.com/tobacco-companies-...External Text duplicate Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
/the-harmful-effects-of-smokin...Subdomain Text duplicate The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
/oncozine.com/oncology-hematol...Subdomain Text duplicate Drug Approvals 2017 – 2020
/oncology-hematology-drug-appr...Subdomain Text duplicate Oncology & Hematology – FDA Drug Approvals 2018
/oncology-hematology-fda-drug-...Subdomain Text duplicate Oncology & Hematology – FDA Drug Approvals 2019
/oncology-hematology-fda-drug-...Subdomain Text duplicate Oncology & Hematology – FDA Drug Approvals 2020
/category/articles/Subdomain Text duplicate Articles
/category/latest-articles/Subdomain Text duplicate Latest Articles
/category/expert-interviews/Subdomain Text duplicate Expert Interviews
/category/editorial-and-commen...Subdomain Text duplicate Editorials and Commentaries
/category/eric-rosenthal-reports/Subdomain Text duplicate Eric Rosenthal Reports
/category/publications-peer-re...Subdomain Text duplicate Publications
/category/news/Subdomain Text duplicate News
/category/business-economics/Subdomain Text duplicate Business & Economics
/category/clinical-development/Subdomain Text duplicate Clinical Development
/category/conference-coverage/Subdomain Text duplicate Conference Coverage
/the_oncozine_brief_episodes/Subdomain Text duplicate The Onco’Zine Brief
/the-oncozine-brief-episodes/Subdomain Text duplicate The Episodes
/the-oncozine-brief-national-a...Subdomain Text duplicate National Advertising
http://www.oncozine.com/New window Subdomain Text duplicate Resources
https://www.oncologydirectory....New window External Subdomain Text duplicate Membership
https://www.oncologydirectory....External Subdomain Text duplicate Agenda
https://www.oncologydirectory....New window External Subdomain Text duplicate Join Today
https://www.oncologydirectory....New window External Subdomain Text duplicate Video
/job-openings/Subdomain Text duplicate Careers
/solutions-to-identify-patient...Subdomain A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/solutions-to-identify-patient...Subdomain Text duplicate Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdomain Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdomain A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/crofelemer-reduces-diarrhea-i...Subdomain Text duplicate Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/study-shows-new-co-star-recep...Subdomain A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/study-shows-new-co-star-recep...Subdomain Text duplicate Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/the-concierge-catch-better-ac...Subdomain A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/the-concierge-catch-better-ac...Subdomain Text duplicate The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/asco-2024-encouraging-dose-es...Subdomain A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/asco-2024-encouraging-dose-es...Subdomain Text duplicate ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/category/featured/Subdomain FEATURED
/solutions-to-identify-patient...Subdomain Text duplicate Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdomain Text duplicate Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdomain Text duplicate Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/author/okhuysen_pc-001/Subdomain Pablo C. Okhuysen, M.D., FACP, FIDSA
/the-concierge-catch-better-ac...Subdomain Text duplicate The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/author/john-rossheim_001a/Subdomain John Rossheim
/the-transformative-potential-...Subdomain The Transformative Potential of Exosome Research in Cancer Detection and Beyond
A-TITLE The Transformative Potential of Exosome Research in Cancer Detection and Beyond
/author/biological_d-hdhani_001/Subdomain Harmeet Dhani, MD, MSc
/a-global-view-of-oncology-inf...Subdomain A Global View of Oncology Informatics
A-TITLE A Global View of Oncology Informatics
/author/maria_dolores-mata-moy...Subdomain María Dolores de la Mata Moya
/standardizing-immunophenotypi...Subdomain Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
/author/leonardo_beretta_001-ad/Subdomain Leonardo Beretta
/experts-forecast-achieving-ca...Subdomain Experts Forecast: Achieving Cancer Health Equity
A-TITLE Experts Forecast: Achieving Cancer Health Equity
/author/neha_j_pancholi_001/Subdomain Neha J. Pancholi, PhD
/the-impact-of-dcisionrt-versu...Subdomain The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
/author/amishi-bajaj-001/Subdomain Amishi Bajaj, MD
/category/newsSubdomain NEWS
/solutions-to-identify-patient...Subdomain Text duplicate Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdomain Text duplicate Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdomain Text duplicate Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/author/okhuysen_pc-001/Subdomain Text duplicate Pablo C. Okhuysen, M.D., FACP, FIDSA
/study-shows-new-co-star-recep...Subdomain Text duplicate Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/author/peter-hofland/Subdomain Peter Hofland
/the-concierge-catch-better-ac...Subdomain Text duplicate The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/author/john-rossheim_001a/Subdomain Text duplicate John Rossheim
/asco-2024-encouraging-dose-es...Subdomain Text duplicate ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/author/editorial_team/Subdomain Editorial Team
/asco-2024-adagrasib-shows-sta...Subdomain ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-a-more-effective-tr...Subdomain ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-asciminib-a-safer-m...Subdomain ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic...
A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-durable-efficacy-of...Subdomain ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-natalee-shows-riboc...Subdomain ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-abbvie-to-showcases...Subdomain ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its...
A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform
/author/editorial_team/Subdomain Text duplicate Editorial Team
/strong-immunology-portfolio-h...Subdomain Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab
A-TITLE Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-encouraging-dose-es...Subdomain Text duplicate ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-adagrasib-shows-sta...Subdomain Text duplicate ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-a-more-effective-tr...Subdomain Text duplicate ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-asciminib-a-safer-m...Subdomain Text duplicate ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic...
A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-durable-efficacy-of...Subdomain Text duplicate ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-natalee-shows-riboc...Subdomain Text duplicate ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-abbvie-to-showcases...Subdomain Text duplicate ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its...
A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform
/author/editorial_team/Subdomain Text duplicate Editorial Team
/asco-2024-bristol-myers-squib...Subdomain ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies
A-TITLE ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies
/author/editorial_team/Subdomain Text duplicate Editorial Team
/encouraging-conversation-acti...Subdomain Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer
A-TITLE Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer
/author/editorial_team/Subdomain Text duplicate Editorial Team
/increased-overall-survival-re...Subdomain Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy
A-TITLE Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy
/author/peter-hofland/Subdomain Text duplicate Peter Hofland
/study-shows-positive-results-...Subdomain Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
A-TITLE Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
/author/editorial_team/Subdomain Text duplicate Editorial Team
/immunotherapy-after-surgery-i...Subdomain Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer
A-TITLE Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer
/author/editorial_team/Subdomain Text duplicate Editorial Team
/category/editorial/Subdomain EDITORIAL
/a-global-view-of-oncology-inf...Subdomain Text duplicate A Global View of Oncology Informatics
A-TITLE A Global View of Oncology Informatics
/author/maria_dolores-mata-moy...Subdomain Text duplicate María Dolores de la Mata Moya
/standardizing-immunophenotypi...Subdomain Text duplicate Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
/author/leonardo_beretta_001-ad/Subdomain Text duplicate Leonardo Beretta
/experts-forecast-achieving-ca...Subdomain Text duplicate Experts Forecast: Achieving Cancer Health Equity
A-TITLE Experts Forecast: Achieving Cancer Health Equity
/author/neha_j_pancholi_001/Subdomain Text duplicate Neha J. Pancholi, PhD
/the-impact-of-dcisionrt-versu...Subdomain Text duplicate The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
/author/amishi-bajaj-001/Subdomain Text duplicate Amishi Bajaj, MD
/forecast-2024-broadening-the-...Subdomain Forecast 2024: Broadening the Reach of Cancer Vaccines
A-TITLE Forecast 2024: Broadening the Reach of Cancer Vaccines
/author/neha_j_pancholi_001/Subdomain Text duplicate Neha J. Pancholi, PhD
/the-digital-frontier-5-ways-o...Subdomain The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care
A-TITLE The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care
/author/jesse-kaestner-001/Subdomain Jesse Kaestner
/category/eric-rosenthal-reports/Subdomain ERIC ROSENTHAL REPORTS
/remembering-emil-jay-freireic...Subdomain Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
A-TITLE Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
/author/erictrosenthal/Subdomain Eric T. Rosenthal
/why-were-top-hhs-officials-in...Subdomain Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
A-TITLE Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
/author/erictrosenthal/Subdomain Text duplicate Eric T. Rosenthal
/category/expert-interviews/Subdomain EXPERT INTERVIEWS
/jason-moore-phd-improving-the...Subdomain Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources
A-TITLE Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources
/author/editorial_team/Subdomain Text duplicate Editorial Team
/sonalasense-developing-a-safe...Subdomain SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer
A-TITLE SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer
/author/danielle_garcia/Subdomain Danielle Garcia
/be-the-match-improving-outcom...Subdomain Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
A-TITLE Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
/author/danielle_garcia/Subdomain Text duplicate Danielle Garcia
/the-oncozine-brief-episodes/Subdomain IMG-ALT spot_img
https://amzn.to/378W1I6External Text duplicate IMG-ALT spot_img
https://amzn.to/3Z0DFEUExternal Text duplicate IMG-ALT spot_img
/solutions-to-identify-patient...Subdomain Text duplicate Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdomain Text duplicate Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdomain Text duplicate Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/author/okhuysen_pc-001/Subdomain Text duplicate Pablo C. Okhuysen, M.D., FACP, FIDSA
/study-shows-new-co-star-recep...Subdomain Text duplicate Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/author/peter-hofland/Subdomain Text duplicate Peter Hofland
/daiichi-sankyo-out-licenses-i...Subdomain Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics
A-TITLE Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics
/author/peter-hofland/Subdomain Text duplicate Peter Hofland
/how-meaningful-will-changes-b...Subdomain How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?
A-TITLE How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?
/author/erictrosenthal/Subdomain Text duplicate Eric T. Rosenthal
/reversal-of-fortune-how-a-vil...Subdomain Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...
A-TITLE Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/author/peter-hofland/Subdomain Text duplicate Peter Hofland
/category/news/Subdomain News2935
/category/conference-coverage/Subdomain Conference Coverage507
/category/research-and-develop...Subdomain Research & Development364
/category/cancer-risk/Subdomain Cancer Risk304
/category/clinical-trial-updates/Subdomain Clinical Trial Updates277
/category/clinical-development/Subdomain Clinical development271
/category/business-economics/Subdomain Business & Economics197
/category/regulatory-updates/Subdomain Regulatory Updates120
/category/op-ed-opinion/Subdomain Op-Ed | Opinion112
/category/must-read-articles/Subdomain Must Read Articles110
https://www.oncozine.com/Subdomain IMG-ALT Onco\'Zine, The International Oncology Network
https://www.facebook.com/oncoz...New window External Subdomain Text duplicate A-TITLE Facebook
https://www.linkedin.com/showc...New window External Subdomain Text duplicate A-TITLE Linkedin
https://soundcloud.com/hofreyNew window External Text duplicate A-TITLE Soundcloud
https://twitter.com/OncoZineNew window External Text duplicate A-TITLE Twitter
https://vimeo.com/channels/877242New window External Text duplicate A-TITLE Vimeo
https://www.youtube.com/channe...New window External Subdomain Text duplicate A-TITLE Youtube
https://www.xing.com/communiti...New window External Subdomain Text duplicate A-TITLE Xing
https://www.oncozine.com/Subdomain Text duplicate Home
/advertisement-sponsorship-opt...Subdomain Text duplicate Advertisement & Sponsorship Options
https://lp.constantcontactpage...External Subdomain Text duplicate Download Our Media Kit
/continued-medical-education-cme/Subdomain Text duplicate Changing Physician Behavior
/cancer-information-by-disease/Subdomain Text duplicate Cancer A – Z
http://www.oncozine.com/Subdomain Text duplicate Drug Developmemt Technologies
/a-novel-technology-based-on-s...Subdomain Text duplicate A Novel Technology based on Somatic Hypermutation (SHM)
/about-oncozine/advisory-board-3/Subdomain Text duplicate Editorial Advisory Board
/join-our-editorial-advisory-b...Subdomain Text duplicate Join Our Editorial Advisory Board
/contact-us/Subdomain Text duplicate Contact Us
/terms-and-conditions/Subdomain Text duplicate Terms and Conditions
/sabcs-and-ash-2023/Subdomain Text duplicate SABCS and ASH 2023
http://www.adcreview.com/External Subdomain Text duplicate ADC Review | J. Antibody-drug Conjugates
https://www.adcreview.com/reso...External Subdomain Text duplicate Resources for For Clinicians
https://www.adcreview.com/adc-...External Subdomain Text duplicate Drug Map (ADC)
https://www.adcreview.com/cate...External Subdomain Text duplicate Peer Review Articles
https://www.adcreview.com/the-...External Subdomain Text duplicate The Review
/changing-strategies-in-the-wa...Subdomain Text duplicate Changing Strategies in the War on Cancer
/changing-strategies-in-the-wa...Subdomain Text duplicate Changing Strategies in the War on Cancer – Episode 1
/changing-strategies-in-the-wa...Subdomain Text duplicate Changing Strategies in the War on Cancer – Episode 2
/changing-strategies-in-the-wa...Subdomain Text duplicate Changing Strategies in the War on Cancer – Episode 3
/centers-of-the-cancer-univers...Subdomain Text duplicate Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
http://cartcelljournal.com/External Text duplicate Journal of CAR T-Cell Therapy
http://cartcelljournal.com/about/External Text duplicate About CAR T-cells
http://cartcelljournal.com/faq/External Text duplicate Frequently Asked Questions
http://cartcelljournal.com/art...External Text duplicate Types of Articles
http://cartcelljournal.com/for...External Text duplicate Submit a Manuscript
/the_oncozine_brief_episodes/Subdomain Text duplicate The Onco’Zine Brief
/the_oncozine_brief_episodes/Subdomain Text duplicate The Network
/the-oncozine-brief-episodes/Subdomain Text duplicate The Episodes
https://www.patreon.com/theonc...New window External Subdomain Text duplicate How to Support The Onco’Zine Brief
/underwriting/Subdomain Text duplicate Corporate Underwriting and Sponsorship
/the-oncozine-dossier/Subdomain Text duplicate The Onco’Zine Dossier
/thalidomide-a-history/Subdomain Text duplicate Thalidomide: A History
/thalidomide-in-the-shadow-of-...Subdomain Text duplicate Thalidomide: In the Shadow of Death
/controversy-the-involvement-o...Subdomain Text duplicate Controversy: The involvement of Ciba AG in the development of Thalidomide
/thalidomides-secret-past-the-...Subdomain Text duplicate Thalidomide’s Secret Past: The Link with Nazi Germany
/reversal-of-fortune-how-a-vil...Subdomain Text duplicate Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/oncozine-dossier-50-years-aft...Subdomain Text duplicate Smoking and Health
/new-surgeon-generals-report-p...Subdomain Text duplicate New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
/smoking-and-the-lost-legacy-o...Subdomain Text duplicate Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
/tobacco-control-in-the-united...Subdomain Text duplicate Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
http://.com/tobacco-companies-...External Text duplicate Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
/the-harmful-effects-of-smokin...Subdomain Text duplicate The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
/oncozine.com/oncology-hematol...Subdomain Text duplicate Drug Approvals 2017 – 2020
/oncology-hematology-drug-appr...Subdomain Text duplicate Oncology & Hematology – FDA Drug Approvals 2018
/oncology-hematology-fda-drug-...Subdomain Text duplicate Oncology & Hematology – FDA Drug Approvals 2019
/oncology-hematology-fda-drug-...Subdomain Text duplicate Oncology & Hematology – FDA Drug Approvals 2020
/category/articles/Subdomain Text duplicate Articles
/category/latest-articles/Subdomain Text duplicate Latest Articles
/category/expert-interviews/Subdomain Text duplicate Expert Interviews
/category/editorial-and-commen...Subdomain Text duplicate Editorials and Commentaries
/category/eric-rosenthal-reports/Subdomain Text duplicate Eric Rosenthal Reports
/category/publications-peer-re...Subdomain Text duplicate Publications
/category/news/Subdomain Text duplicate News
/category/business-economics/Subdomain Text duplicate Business & Economics
/category/clinical-development/Subdomain Text duplicate Clinical Development
/category/conference-coverage/Subdomain Text duplicate Conference Coverage
/the_oncozine_brief_episodes/Subdomain Text duplicate The Onco’Zine Brief
/the-oncozine-brief-episodes/Subdomain Text duplicate The Episodes
/the-oncozine-brief-national-a...Subdomain Text duplicate National Advertising
http://www.oncozine.com/New window Subdomain Text duplicate Resources
https://www.oncologydirectory....New window External Subdomain Text duplicate Membership
https://www.oncologydirectory....External Subdomain Text duplicate Agenda
https://www.oncologydirectory....New window External Subdomain Text duplicate Join Today
https://www.oncologydirectory....New window External Subdomain Text duplicate Video
/job-openings/Subdomain Text duplicate Careers
https://lp.constantcontactpage...New window External Subdomain No Text

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.oncozine.com/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time is slow (1.01 seconds). The response time should be less than 0.4 seconds. Slow websites are bad for search engine bots and also result in bad user experience.
The file size of the HTML document is fine (221 kB).

HTTP Response Header

NameValue
servernginx
dateSun, 14 Jul 2024 05:25:10 GMT
content-typetext/html; charset=UTF-8
varyAccept-Encoding
x-cache-enabledTrue
link<https://www.oncozine.com/wp-json/>; rel="https://api.w.org/", <https://www.oncozine.com/wp-json/wp/v2/pages/6893>; rel="alternate"; type="application/json", <https://www.oncozine.com/>; rel=shortlink
x-httpd1
x-cdn-call
content-encodinggzip
x-sg-cdn1
x-proxy-cacheHIT
host-header8441280b0c35cbc1147f8ba998a563a7
statuscode200
http_versionHTTP/2

External factors

Blacklists
(Nice to have)
This website is not classified "for adult only".
This website has excellent links from other websites.
This page has backlinks from 333 referring domains.
This page has 1,075 backlinks.
This page has backlinks from 260 different ip addresses.
Facebook popularity
(Somewhat important)
The page has 0 shares and comments on Facebook.

Links from Wikipedia

No links from Wikipedia were found.

Robots.txt

# START WPFORMS BLOCK
# ---------------------------
User-agent: *
Disallow: /wp-content/uploads/wpforms/
# ---------------------------
# END WPFORMS BLOCK

# START YOAST BLOCK
# ---------------------------
User-agent: *
Disallow:

Sitemap: https://www.oncozine.com/sitemap_index.xml
# ---------------------------
# END YOAST BLOCK

Similar sites

Search preview

www.oncozine.com
Home - Onco'Zine - A part of the Oncology and Hematology News ...
Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Onco95%Check
Onco Zine94%Check
Zine91%Check
Oncology80%Check
Oncology Network78%Check
Network76%Check
Onco Zine Brief75%Check
Oncology Hematology69%Check
News Network69%Check
Hematology News Network65%Check
Show more keywords and terms

Test up to 1.000 webpages of oncozine.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions